# SYTL1

## Overview
Synaptotagmin-like 1 (SYTL1) is a gene that encodes the synaptotagmin-like protein 1, a cytoplasmic protein involved in intracellular vesicle trafficking. This protein plays a pivotal role in exocytosis and endocytosis by interacting with Rab GTPases, which are essential regulators of vesicle movement. SYTL1 is particularly significant in processes such as neurotransmitter release, hormone secretion, and immune responses, where it regulates vesicular trafficking and exocytosis. The protein's interactions with other molecules, such as GMIP and RhoA, further underscore its role in cellular communication and signaling. SYTL1's involvement in the trafficking of cytokine and chemokine receptors, such as CXCR4, highlights its importance in cell migration and disease mechanisms, including cancer and leukemogenesis (Meijuan2023Synaptotagminlike; Johnson2012Vesicular; Yokoyama2016MEIS1-mediated).

## Function
Synaptotagmin-like protein 1 (SYTL1) is involved in intracellular vesicle trafficking and plays a crucial role in exocytosis and endocytosis. It interacts with Rab GTPases, which are key regulators of vesicle movement, facilitating processes such as neurotransmitter release and hormone secretion. SYTL1 is active in the cytoplasm and is essential for cellular communication and signaling (Meijuan2023Synaptotagminlike).

In neutrophils, SYTL1, also known as JFC1, regulates vesicular trafficking and exocytosis by organizing the actin cytoskeleton around secretory granules. This organization prevents actin polymerization, allowing granules to move towards the exocytic active zone, which is crucial for innate immunity and inflammation (Johnson2012Vesicular). SYTL1's interaction with GMIP and its influence on RhoA-GAP activity are important for the inactivation of RhoA around granules, promoting vesicular transport (Johnson2012Vesicular).

SYTL1 also plays a role in the trafficking of cytokine and chemokine receptors, such as CXCR4, which is part of the CXCL12/CXCR4 signaling axis. This trafficking is essential for cell migration and engraftment, particularly in the context of leukemogenesis (Yokoyama2016MEIS1-mediated). SYTL1's involvement in these processes highlights its importance in cellular physiology and its potential impact on disease mechanisms.

## Clinical Significance
Synaptotagmin-like protein 1 (SYTL1) has been implicated in various diseases due to alterations in its expression and interactions. In endometrial cancer (EC), SYTL1 is significantly upregulated in cancerous tissues compared to non-cancerous ones. Its expression is associated with clinical parameters such as age, clinical stage, and histological type, and it is considered an independent prognostic factor for Uterine Corpus Endometrial Carcinoma (UCEC) patients. Higher SYTL1 expression is linked to better overall survival, suggesting its potential as a diagnostic and prognostic biomarker in EC (Meijuan2023Synaptotagminlike).

In the context of acute myeloid leukemia (AML), SYTL1 is a transcriptional target of MEIS1 and cooperates with HOXA9 to promote leukemic cell engraftment and interaction with stromal cells. SYTL1 is crucial for CXCL12/CXCR4 signaling, which is significant in leukemogenesis. Knockdown of SYTL1 in AML cells results in decreased cellular migration and extended survival in mouse models, indicating its role in leukemogenesis. SYTL1 expression is coexpressed with MEIS1 and HOXA9 in certain AML subgroups, suggesting its potential as a prognostic marker in these cases (Yokoyama2016MEIS1-mediated).

## Interactions
Synaptotagmin-like 1 (SYTL1) is involved in various protein interactions that facilitate intracellular trafficking and membrane dynamics. SYTL1 interacts with members of the Rab family of small GTPases, such as Rab27a and Rab27b, which are crucial for vesicle transport and secretion processes. These interactions are significant in the context of leukemogenesis, where SYTL1 facilitates the trafficking of CXCR4, a receptor involved in the CXCL12/CXCR4 signaling axis, enhancing leukemic cell migration and engraftment (Yokoyama2016MEIS1-mediated).

In endometrial cancer, SYTL1 is part of a network of genes involved in transport vesicle functions, interacting with proteins like RAB27A and MYRIP, which are identified as functional partners through network analysis (Meijuan2023Synaptotagminlike). SYTL1 also forms a complex with Rab27a and CD81, which is crucial for the secretion of exosomes in lung adenocarcinoma cells, highlighting its role in cancer metastasis inhibition (Huang2023LincRNA01703).

These interactions underscore SYTL1's role in modulating cellular processes through its involvement in vesicle docking and fusion, contributing to its function in various pathological conditions.


## References


[1. (Meijuan2023Synaptotagminlike) Cai Meijuan, Xu Meng, Liu Fang, and Wang Qian. Synaptotagmin-like protein 1 is a potential diagnostic and prognostic biomarker in endometrial cancer based on bioinformatics and experiments. Journal of Ovarian Research, January 2023. URL: http://dx.doi.org/10.1186/s13048-023-01097-2, doi:10.1186/s13048-023-01097-2. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13048-023-01097-2)

[2. (Johnson2012Vesicular) Jennifer L. Johnson, Jlenia Monfregola, Gennaro Napolitano, William B. Kiosses, and Sergio D. Catz. Vesicular trafficking through cortical actin during exocytosis is regulated by the rab27a effector jfc1/slp1 and the rhoa-gtpase–activating protein gem-interacting protein. Molecular Biology of the Cell, 23(10):1902–1916, May 2012. URL: http://dx.doi.org/10.1091/mbc.e11-12-1001, doi:10.1091/mbc.e11-12-1001. This article has 83 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e11-12-1001)

[3. (Huang2023LincRNA01703) Yun Huang, Shan Guo, Ying Lin, Liyun Huo, Hongmei Yan, Zhanwen Lin, Zishuo Chen, Junchao Cai, Jueheng Wu, Jie Yuan, Hongyu Guan, Guoyong Wu, Weibin Wu, and Tianyu Tao. Lincrna01703 facilitates cd81+ exosome secretion to inhibit lung adenocarcinoma metastasis via the rab27a/sytl1/cd81 complex. Cancers, 15(24):5781, December 2023. URL: http://dx.doi.org/10.3390/cancers15245781, doi:10.3390/cancers15245781. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers15245781)

[4. (Yokoyama2016MEIS1-mediated) Takashi Yokoyama, Mayuka Nakatake, Takeshi Kuwata, Arnaud Couzinet, Ryo Goitsuka, Shuichi Tsutsumi, Hiroyuki Aburatani, Peter J.M. Valk, Ruud Delwel, and Takuro Nakamura. Meis1-mediated transactivation of synaptotagmin-like 1 promotes cxcl12/cxcr4 signaling and leukemogenesis. Journal of Clinical Investigation, 126(5):1664–1678, March 2016. URL: http://dx.doi.org/10.1172/jci81516, doi:10.1172/jci81516. This article has 29 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci81516)